Information for: Alumni Prospective Students Current Students

Population Aging Research Center

Home
About Us
- About Us
- Contact PARC
People
Research
Working Papers
Publications
Services
News & Events
Pilot Awards
- Pilot Awards
- Quartet Pilot Project Competition
Training
Allied Centers

NIH Funding Opportunities (Notices, PA, RFA)

Requirement for Electronic Submission of All Administrative Supplements
July 5 Due Date Reminder
Notice of Special Interest: Research to Advance the Understanding and Management of the Multiple Organ Dysfunction Syndrome in Children (R01, R21)
Notice of Pre-Application Webinar for PAR-20-017 "Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
Notice to Extend the Response Date for NOT-AR-20-009 "Request for Information (RFI): Input to Advance Artificial Intelligence (AI)-ready Data Generation and Scalable Computational Approaches in NIAMS Research"
Inclusion Reporting and FORMS-F
What Is a “Rolling” Submission Date?
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
Network of the National Library of Medicine Evaluation Center (U24) (Clinical Trial Not Allowed)
Complexity of human tooth enamel revealed at atomic level in NIH-funded study
NIH taps Dr. Shannon Zenk as director of the National Institute of Nursing Research
NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development
Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)
Notice of Early Expiration of PAR-18-735 (Investigator-Initiated Genomic Medicine Research (R01 Clinical Trial Optional) and PAR-18-736 (Investigator-Initiated Genomic Medicine Research (R21 Clinical Trial Optional)
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide RPG (R01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R34 Clinical Trial Optional)
Notice of NCI's Participation in PA-20-025, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
Notice of NCI's Participation in PA-20-047, Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional)
Many New and Updated COVID-19 FAQs
Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed)
Biomarkers of Dietary Intake and Exposure (U2C Clinical Trial Required)
Findings of research misconduct
Testimony on Operation Warp Speed: Researching, Manufacturing, & Distributing a Safe & Effective Coronavirus Vaccine
Notice to Extend the Expiration Date for PAR-17-287 "NIA Academic Leadership Career Award (K07)"
Notice of NIAMS Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Notice of Participation of NCCIH in PAR-19-342, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
Notice of Participation of NCCIH in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
Request for Information (RFI): Seeking Stakeholder Input on Scientific Gaps and Research Needs Related to Delivery of Cancer-related Care via Telehealth
Notice of Clarification to Application Types Allowed PAR-20-111 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
Notice of Changes to the Dates in the Final Receipt, Review, Council, and Award Cycle and to the Expiration Date of PAR-19-101, "Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)"
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
Notice of Change to Key Dates for RFA-NS-20-030 "Research Program Award (R35 Clinical Trial Optional)"
Long-acting injectable form of HIV prevention outperforms daily pill in NIH study
Notice of Participation in PA-18-358, "NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)"
Iodine exposure in the NICU may lead to decrease in thyroid function, NIH study suggests
Notice to Add a Receipt Date to RFA-DA-21-019 Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for ALACRITY Centers for Practice-Based Effectiveness and Services Research with Near-Term Impact (P50 Clinical Trial Optional)
Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
A Conversation on COVID-19 featuring Drs. Francis Collins and Anthony Fauci
Notice of Additional Eligibility Information in PAR-20-100 Genomic Community Resources (U24)
Notice Announcing the National Institute of Mental Health (NIMH) Expectations for Collection of Common Data Elements
Notice of Change to Instructions for Human Subjects and Clinical Trial Information in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)
Notice of Change to Instructions for Human Subjects and Clinical Trial Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)"
Notice of New Budget Limitation for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)"
Notice of Change to Application Receipt Dates and Clarification of Eligibility Information for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools
Outdoor light linked with teens’ sleep and mental health
Addressing Foreign Interference and Associated Risks to the Integrity of Biomedical Research, and How You Can Help
NfL outperforms other blood tests to predict and diagnose traumatic brain injury
Blood-based biomarker can detect, predict severity of traumatic brain injury
Individually tailored falls prevention plan found no better than usual care for reducing serious injury
NIH researchers reframe dog-to-human aging comparisons
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative
Notice of Clarification to Key Dates for RFA-CA-20-039 "Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)"
Notice to Extend Response Date for NOT-GM-20-034: "Request for Information: Soliciting Input on the NIGMS 2021-2025 Strategic Plan Framework"
Notice of Change to Key Dates for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)".
Notice of Change to Key Dates for PAR-19-039 "Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)"
Notice of Change to Key Dates for PAR-19-040 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)"
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
A call for stimulating diversity in brain research
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
Notice of Special Interest: Epidemiology and Prevention in Alcohol Research
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed
Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01 Clinical Trial Not Allowed)
Grant and Contract Submission Requirements Regarding the Updated AVMA Guidelines for the Euthanasia of Animals: 2020 Edition
NIH-Wide Strategic Plan for COVID-19 Research Now Available
Turning off “junk DNA” may free stem cells to become neurons
DNA changes linked to endometriosis
Faster, better images from cutting-edge microscopes
Advanced imaging reveals structure of tooth enamel
Notice of Intent to Publish a Funding Opportunity Announcement for Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Notice of Expiration of PAR-20-178 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)"
PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
Pre-Application Webinar for RFA-CA-20-042, 3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)
Placenta lacks major molecules used by SARS-CoV-2 virus to cause infection
Notice of Special Interest: Notice of Availability of Funds for Administrative Supplements for Pediatric Radiation/Nuclear Animal Models, MCM, Biodosimetry Development
NIH researchers generate complete human X chromosome sequence
Experimental COVID-19 vaccine safe, generates immune response
Notice of Expiration of PAR-20-177 "Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)"
NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)
NINDS Morris K. Udall Parkinson's Disease Research Center Without Walls (P20 Clinical Trial Optional)
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional)
Notice to allow IDDRCs to put URLs in applications
Notice of Amendment of NCI Participation in PAR-20-164, Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Methods Development in Natural Products Research (SBIR/STTR)
Notice of Early Expiration of PAR-19-060 NINR Clinical Trial Planning Grant (R34 Clinical Trial Required)
Limited Competition: International Agency for Research on Cancer (IARC) Monographs Program (R01 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations
Extramural Loan Repayment Program for Contraception and Infertility Research (LRP-CIR)
Extramural Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds (LRP-IDB)
Extramural Loan Repayment Program for Health Disparities Research (LRP-HDR)
Extramural Loan Repayment Program for Pediatric Research (LRP-PR)
Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)
Notice to Extend NCCIH's PAR-18-417, Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34, Clinical Trial Required)
Notice to Extend the Response Date for NOT-MH-20-051, "Request for Information (RFI): Advancing Scientific and Workforce Diversity in the BRAIN Initiative"
BRAIN Initiative: Tools for Germline Gene Editing in Marmosets (U01 - Clinical Trial Not Allowed)
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
On NBC’s Meet the Press, Dr. Collins talks about the current surge of COVID-19 cases, and the importance of accelerating vaccine and diagnostic development
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
NIEHS Research Intensive Short Courses and Educational Opportunities (NIEHS RISE) (R25 Clinical Trial Not Allowed)
Notice of Change: Extension to end date for NOT-OD-20-130 RFI: Enhancing Rigor, Transparency, and Translatability to Improve Biomedical Research Involving Animal Models
Useful Flexibilities for Animal Care and Use Programs to Comply with the PHS Policy During the COVID-19 Pandemic
Request for Proposal (RFP) Notice: NHLBI Progenitor Cell Translational Consortium (PCTC) - Scientific Services to Conduct In-depth Cell Characterization for the NIH Regenerative Medicine Innovation Project 2020
New “All About Grants” Podcast – Invention Reporting and Patent Protections for Grantees
NIH study shows highly reproducible sex differences in aspects of human brain anatomy
Experimental coronavirus vaccine is safe and produces immune response
Exercise-induced protein may reverse age-related cognitive decline
Stopping scar tissue improves healing after heart attack in mice
Notice to Reduce the Number of Research Projects Required in PAR-19-312 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)"
Notice of Special Interest: Fundamental and Translational Research on Decision Making in Aging and/or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD)
Notice of Change to Key Dates and Post Submission Materials Guideline in RFA-CA-20-033, "SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)"
Notice of Correction to PAR-20-221, "NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional)"
Notice to Reduce the Number of Research Projects Required in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)"
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
AHRQ Grant Recipient use of the eRA Commons to Submit First-Time No-Cost Extension (NCE) Notifications for Grant Awards that are under Expanded Authorities
Request for Information (RFI) on Flexibilities for Conducting Semiannual Animal Facility Inspections
Notice of Pre-Application Webinar for Developmental Genotype-Tissue Expression Project (dGTEx)
Notice of Change to the Application Instructions for the Candidate Eligibility Statement in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
Notice of Change to Award Information in PAR-19-242, Paul Calabresi Career Development for Clinical Oncology (K12 Clinical Trial Optional)
Limited Competition for the Continuation of the Look AHEAD (Action for Health in Diabetes) Study (U01 Clinical Trial Not Allowed)
NIH leadership details unprecedented initiative to ramp up testing technologies for COVID-19
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
Notice of Special Interest (NOSI): Improving Methods to Assess Body Composition in Infants and Young Children
Notice of Change: Clarification of Budget for PA-20-227 "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
Notice to Extend PA-17-246
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)
Kidney transplantation between people with HIV is safe, NIH study finds
Dual role discovered for molecule involved in autoimmune eye disease
In a NEJM Special Report, Dr. Collins and NIH leadership detail NIH’s effort to ramp up testing technologies for COVID-19
Dr. Collins talks to STAT about the current state of vaccine development efforts and upcoming clinical trials for COVID-19 treatments
Dr. Collins joins ABC News’ Vaccine Watch to discuss the latest developments in the search for a COVID-19 vaccine
Dr. Collins and CBS News’ Norah O’Donnell discuss the public and private sectors unprecedented efforts to develop a COVID-19 vaccine
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Hubs (U54 Clinical Trial Optional)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Research Training Program (U2R Clinical Trial Optional)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa): Ethical, Legal, and Social Implications Research (U01 Clinical Trial Not Allowed)
Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) Open Data Science Platform and Coordinating Center (U2C Clinical Trial Not Allowed)
Dr. Collins participates in a U.S. News Live webinar to discuss COVID-19 vaccines, treatments, testing, and more
New Vertebrate Animals Section Training Module
Notice of Intent to Publish a Funding Opportunity Announcement for a Coordinating Center for New Cohorts to Assess Environmental Exposures and Cancer Risk (U24 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for New Cohorts to Assess Environmental Exposures and Cancer Risk (UG3/UH3 Clinical Trial Optional)
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (SDCC) (U24 - Clinical Trial Not Allowed)
Notice of NHLBI Participation in NOT-OD-20-097 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences"
Notice of Expiration of NOT-HL-20-782 "Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials"
Notice of NHLBI Participation in NOT-OD-20-097 "NOSI regarding Availability of Admin Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences
Notice of NHLBI Participation in NOT-OD-20-119 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
Notice of NHLBI Participation in NOT-OD-20-120 "Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
Notice of NHLBI Participation in NOT-OD-20-121 "Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations"
Extension of the World Trade Center Health Registry (U50)
Notice of Early Expiration of PAR-20-269 Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
Vaginal ring for HIV prevention receives positive opinion from European regulator
NIH selects Dr. Michael Chiang as director of the National Eye Institute
First-ever research network tackles diabetic foot complications
Dr. Collins explains to MSNBC’s Ali Velshi NIH’s role in safely accelerating COVID-19 vaccine development
Phase 3 clinical trial of investigational vaccine for COVID-19 begins
Notice of information to PAR-18-746, " NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)"
Notice of Information: FNIH Cancer Steering Committee Project Concepts for Novel Biomarker Platforms in Understanding Tumor Heterogeneity
NIH to invest $58M to catalyze data science and health research innovation in Africa
Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01 Clinical Trial Optional)
During a U.S. News Live webinar, Dr. Collins talks about efforts to accelerate the development of a safe and effective COVID-19 vaccine
Fewer hip fractures may be associated with reductions in smoking, heavy drinking
What goosebumps are for
Sex differences in brain anatomy
Approach to prevent fall injuries no better than usual care
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional)
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional)
Policy Update - Results Information Reporting for Applicable Clinical Trials (ACTs)
Notice of ORWH's and NICHD's Participation in PAR-20-179, "Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)"
Dr. Collins and Pfizer’s Dr. Freda Lewis-Hall discuss how public-private partnerships can help expedite scientific progress and how these sectors are working together to respond to the COVID-19 pandemic
An Early Look at Applications Submitted During the Pandemic
The NINDS Human Biospecimen and Data Repository (U24 Clinical Trial Not Allowed)
Notice of Correction to Eligibility Information in PAR-20-278 "NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed)"
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U54 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Not Allowed)
Notice of Change to Application Types Allowed in Funding Opportunity Announcement PAR-19-361 "Small Cell Lung Cancer (SCLC) Consortium: Biology, Therapy and Resistance (U01 Clinical Trial Not Allowed)"
Notice of Correction to PAR-20-225, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"
Notice of ORWH's and NICHD's Participation in PAR-20-180, "Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)"
Experimental COVID-19 vaccine protects upper and lower airways in nonhuman primates
Notice of Technical Assistance Webinars for Harnessing Data Science for Health Discovery and Innovation in Africa (DS-I Africa) RFAs: RFA-RM-20-015, RFA-RM-20-016, RFA-RM-20-017, RFA-RM-20-018
Notice of Termination: PAR-20-136 "Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)"
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
Notice of Extension of the Expiration Date of PAR-18-655 "Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
Notice to Extend the Expiration Date of PAR-18-189 Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
NCCIH Policy Change to Budget Limit and Grant Durations for SBIR/STTR Phase I and Phase II Applications
Findings of Research Misconduct
Request for Information (RFI) on Clarification of Institutional Responsibilities Regarding Grant to Protocol Congruency
Solicitation of Nominations for the 2021 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
Notice of Pre-Application Webinar for the Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium
Notice of Pre-Application Information Webinar for RFA-DA-21-009, "Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)"
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional)
Request for Information (RFI):Advancing Biomarker Research and Implementation to Personalize Health Services Delivery for Tobacco Use Disorder
Notice to Extend the Expiration Date of PAR-18-190 Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Transition to Aging Research for Predoctoral Students (F99/K00)
Notice of Extension of the Expiration Date of PAR-18-654 "Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)"
Notice of Correction to PAR-19-223, "Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"
NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
NHLBI Withdraws Participation in NOT-MD-20-022 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations"
NIH-funded project creates an encyclopedia detailing the inner workings of the human and mouse genomes
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)
Accelerating Clinical Care and Research through the Use of the United States Core Data for Interoperability (USCDI)
Notice of NIDCR's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R21, Clinical Trial Optional)
Investigator-Initiated Research on Genetic Counseling Processes and Practices (R01, Clinical Trial Optional)
Roundup of New COVID-19 Resources for NIH Applicants and Recipients: Part 3
NIH researchers discover new set of channels connecting malaria parasite and blood cells
Limited Competition: Clinical Centers for Completion of Ongoing MFMU Network Protocols (UG1 Clinical Trial Optional)
Limited Competition: Data Coordinating Center (DCC) for Completion of Ongoing MFMU Network Protocols (U24 Clinical Trial Optional)
Leveraging Standardized Clinical Data to Advance Discovery
Upcoming Changes to the Notice of Award (NoA) Beginning October 1, 2020
Notice of Intent to Publish a Funding Opportunity Announcement for HEALthy Brain and Child Development Study
Notice of Informational Webinar on the NIH Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Program Funding Opportunity Announcements (UE5 and K99/R00)
Inclusion Across the Lifespan II Workshop: September 2, 2020
Dr. Collins and NIBIB Director Dr. Bruce Tromberg discuss new COVID-19 testing technologies awarded through the RADx initiative
NPR reports on NIH awards for new COVID-19 testing technologies
Changes to Notice of Award Coming October 1
NIH delivering new COVID-19 testing technologies to meet U.S. demand
Developing Predictive Models of the Impact of Genomic Variation on Function (U01 Clinical Trial Not Allowed)
Systematic Characterization of Genomic Variation on Genomic Function and Phenotype (UM1 Clinical Trial Not Allowed)
Defining Genomic Influence on Gene Network Regulation (U01 Clinical Trial Not Allowed)
Single-cell Profiling of Regulatory Element and Gene Activity in Relationship to Genome Function (UM1 Clinical Trial Not Allowed)
Genomic Variation and Function Data and Administrative Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Special Interest: Basic and Translational Research on Affective, Motivational, and Social Function in Normative Aging and/or Alzheimers Disease and Related Dementias (AD/ADRD)
Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P30 Clinical Trial Not Allowed)
Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional)
Screening drug additives for biological activity
High blood sugar may blunt benefits of aerobic exercise
Potent neutralizing antibodies target new regions of coronavirus spike
Save the Date: Fall 2020 NIH Virtual Seminar on Program Funding and Grants Administration!
Dr. Collins talks with PBS Amanpour and Company’s Walter Isaacson on the latest in COVID-19 research
Dr. Anthony Fauci and Dr. Collins discuss launch of NIH clinical trials to test antibody treatments in COVID-19 patients
NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients
NIH clinical trial to test antibodies and other experimental therapeutics for mild and moderate COVID-19
Notice of Change to First AIDS Application Due Date for PAR-20-233 "Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI): Platform Trials of Thrombectomy in Acute Stroke Treatment
Notice of Change to the Eligibility of Foreign Components in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00)"
Notice to Clarify and Correct Eligibility in Notices of Special Interest under the Rapid Acceleration of Diagnostics Underserved Populations (RADx-UP) Program
Notice of Special Interest (NOSI): Discovery of Analgesic Natural Products through the NINDS IGNITE Program
Notice of Special Interest: Sex and Gender Differences in Alzheimers Disease and Alzheimers Disease-Related Dementias (AD/ADRD)
Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional)
Request for Information (RFI): Strategic Opportunities and Challenges for the National Library of Medicine, National Institutes of Health.
Note of Change to Application Due Dates for PAR-19-295 "Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in Biomedical Sciences (R01 - Clinical Trial Not Allowed)"
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)
NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed)
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
Notice of Correction to PAR-20-224, "Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional)"
Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-NS-19-043 and RFA-NS-19-044" K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity"
Notice of Change to Funding Announcement (NOT-OD-20-048) by the Office of Research on Women's Health (ORWH), " Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)"
NIH Announces the Open Period of FY 2021 Helium-3 Requests for Medical Research
NIH-Moderna investigational COVID-19 vaccine shows promise in mouse studies
Notice of Correction to RFA-OD-20-013 "Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)" for Award Information about Clinical Trials
Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistance
CBS highlights NIH’s launch of ACTIV-2 and ACTIV-3 to develop monoclonal antibody treatment for COVID-19
NIH harnesses AI for COVID-19 diagnosis, treatment, and monitoring
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Wastewater Surveillance Research for Public Health Response to Coronavirus Disease 2019 (COVID-19).
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Chemosensory Testing as a COVID-19 Screening Tool
Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)
Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)
Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)
Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)
Request for Information (RFI): Adolescent Medicine Trials Network for HIV/AIDS Interventions
Mechanisms of Pathological Spread of Abnormal Proteins in LBD and FTD (R01 Clinical Trial Not Allowed)
NIH clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment begins
NIH taps Dr. Lindsey Criswell as director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases
New tool compares rates of severe pregnancy complications across U.S. hospitals
NIH-funded project seeks to identify children at risk for MIS-C
Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
Dr. Collins talks to the Wall Street Journal about his personal faith journey, concerns over vaccine hesitancy and health disparities spotlighted by COVID-19
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
Notice of Change to Key Dates for PAR-18-528 "NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)"
Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data
Temporary Extension of Applicant Eligibility in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of Change to RFA-DA-21-005 "Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)"
Clinical trials of monoclonal antibodies to prevent COVID-19 now enrolling
Notice of Change: Late Application Policy for September 28, 2020, Application Due Date for RFA-NS-21-001 "NINDS Morris K. Udall Centers of Excellence for Parkinson's Disease Research (P50 Clinical Trial Optional)"
Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
Notice of Change: Late Application Policy for September 28, 2020, Application Due Date for RFA-NS-21-002 "NINDS Exploratory Grant Program in Parkinson's Disease Research (P20- Clinical Trial Optional)"
Notice of Change to Key Dates for PAR-18-563 "NIH StrokeNet Small Business Innovation Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (U44 - Clinical Trial Optional)"
Drs. Collins and Wolinetz pen a JAMA Viewpoint remembering Henrietta Lacks on her 100th birthday and calling for the establishment of stronger biospecimen consent policies.
Notice of Change to Key Dates for PAR-18-628 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)"
Notice to Extend Eligibility for Submission to PAR-19-371, NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) due to COVID-related Disruptions
Notice of Special Interest (NOSI): Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Health Disparity Populations
Multifocal contact lenses slow myopia progression in children
Request for Information (RFI): Inviting Comments and Suggestions on University-Based Approaches for COVID-19 Surveillance Testing to Review the Current Landscape
Institute and Center Award Rates and Funding Disparities
Notice Regarding Revision and New Applications under PAR-15-352: Occupational Safety and Health Training Project Grants (T03)
Notice Regarding New ERC Applications for PAR-15-303: Occupational Safety and Health Education and Research Centers (T42)
NHLBI confirms participation in NOT-OD-20-119, NOT-OD-20-120, and NOT-OD-20-121 (Research on COVID-19 Testing among Underserved and/or Vulnerable Populations)
Notice of Correction to "PAR-20-235, Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required)"
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)
Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During COVID-19 Pandemic
New treatments spur sharp reduction in lung cancer mortality rate
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Required)
Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
Mechanisms of Selective Vulnerability in LBD and FTD (R01 Clinical Trial Not Allowed)
NIH Helps Small Businesses Change the World
Mapping tool highlights NIH-funded small business successes
Notice of Technical Assistance Webinar for Two NIH Multimorbidity FOAs - PAR-20-179 and PAR-20-180
Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities
Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2
Notice to Encourage Eligible NINDS Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) Awardees to Apply for PA-20-222 "Research Supplements to Promote Diversity in Health-Related Research"
Notice of Early Expiration of NOT-AI-20-051 Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
NIH names Dr. Rena D’Souza as director of the National Institute of Dental and Craniofacial Research
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed)
Notice of Intent to Publish a Funding Opportunity Announcement for Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
NIH-Supported Scientists Demonstrate How Genetic Variations Cause Eczema
Liver Cirrhosis Network: Scientific and Data Coordination Center (U24 Clinical Trial Optional)
Liver Cirrhosis Network: Clinical Research Centers (U01 Clinical Trial Required)
NIH Will Continue to Accept Preliminary Data as Post-Submission Material Through May 2021 Council
Dr. Collins talks about COVID-19 vaccine hesitancy and trusting the science in an interview with Fox News
Speaking to MSNBC, Dr. Collins stresses the importance of wearing a face covering and provides an update on COVID-19 vaccine trials
Research to Improve Native American Health (R21 Clinical Trials Optional)
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support
NICHD Program Project Grants for HIV Research (P01 Clinical Trial Optional)
Findings of Research Misconduct
Immune cells for common cold may recognize SARS-CoV-2
Blood tests show promise for early Alzheimer’s diagnosis
Multifocal contact lenses slow myopia progression in children
Notice of NLM Participation in PAR-20-150 "NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional)"
Notice of Change to RFA-AG-21-003 New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed)
Drugs against alpha-ketoglutarate may combat deadly childhood brain tumor
NIH study suggests opioid use linked to pregnancy loss, lower chance of conception
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed).
Notice of Pre-Application Webinars for the Impact of Genomic Variation on Function (IGVF) Consortium FOAs (RFA-HG-20-043, RFA-HG-20-044, RFA-HG-20-045, RFA-HG-20-046, RFA-HG-20-047)
Notice of NHLBI Participation in PAR-19-098 "Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)"
Notice of Special Interest: Alcohol and Aging
Notice of Intent to Publish Funding Opportunity Announcements for Music and Health: Understanding And Developing Music Medicine (R01)
Notice of Intent to Publish a Funding Opportunity Announcement for Music and Health: Understanding And Developing Music Medicine (R21)
Small set of genes may provide unique barcode for different types of brain cells in worms
Notice of Intent to Publish a HEAL Funding Opportunity Announcement for Research on Related DSM-5 Diagnoses (R2D2) Coordination and Dissemination Center
Notice to Extend Eligibility for Submission of NIAID K99 /R00 Pathway to Independence Award Applications (and Physician-Scientist K99/R00) due to COVIDrelated Disruptions
Notice of Special Interest: Administrative Supplements to Support Emerging Physician-Scientists to Develop Research Expertise in Diabetes, Endocrinology and Metabolic Diseases
Notice of Participation of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) in PAR-19-064: Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
Visualization Methods and Tools Development for Enhancing Cancer Moonshot Data (R33 Clinical Trial Not Allowed)
Notice of Pre-Application Webinars for the NHGRI Genomic Innovator Award
Notice of Revision to Funding Opportunity Description for RFA-DK-20-017: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 - Clinical Trial Not Allowed)
Notice of Informational Webinar on PAR-20-213: National Institute of General Medical Sciences Predoctoral Institutional Research Training Grant (T32 - Clinical Trial Not Allowed)
Notice of Revision to Funding Opportunity Description for RFA-DK-20-018, Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium Renal Science Core (U01 - Clinical Trial Not Allowed)
Findings of Research Misconduct
Notice of NIMHD Withdrawal from Participation in PA-20-195 and PA-20-196: NIH Exploratory/Developmental Research Grant Programs (Parent R21 Clinical Trial Not Allowed) and (Parent R21 Basic Experimental Studies with Humans Required)
Notice of Change to Key Dates for RFA-NS-18-021 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Required)"
Notice of Revision to Funding Opportunity Description for RFA-DK-20-019, Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Scientific Data Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-NS-18-023 "BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Required)"
Notice of Change to Key Dates for RFA-NS-18-022 "BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required)"
Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
Notice of Temporary Extension of Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00)
Notice of Intent to Publish a HEAL Funding Opportunity Announcement for Consortium on Co-managing Chronic Pain and Opioid Use Disorder (C3PO) (RM1)
Notice of NHLBI Participation in PAR-18-901 "Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional)"
Notice of Participation in RFA-OD-20-023, "Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)"
Request for Information (RFI): Information and Data Resources Needed by the Health Services Research Community for Research and Practice.
Notice of Expiration of NOT-EB-20-007 "Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)"
Notice of Expiration of NOT-EB-20-008: Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
RESolution of InflammaTion in EnvirOnmentally Related diseasE (RESTORE) (R01 Clinical Trial Not Allowed)
Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)
Notice of Expiration of NOT-EB-20-006 "Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)"
Notice of NHLBI Participation in PAR-19-051 "Emerging Global Leader Award (K43 Independent Clinical Trial Required)"
Center without Walls for Molecular Mechanisms of Neurodegeneration in Frontotemporal Degeneration (FTD) (U54 Clinical Trial not Allowed)
Notice of Change to Research and Related Other Project Information (Pilot and Feasibility Program) Instructions for RFA-DK-20-002: NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
Notice of Change: Emphasizing an Opportunity for New Institutional Applicants in Response to PAR-19-204 Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)
NCI Pediatric In Vivo Testing Program (U01 Clinical Trial Not Allowed)
NCI Pediatric In Vivo Testing Program Coordinating Center (U24 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-NS-18-012 "Translational Neural Devices (U44 Clinical Trial Required)"
Notice of Application Due Date Change for RFA-HL-20-021 "Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed)"
Notice of Change to RFA-AG-21-026 Preclinical Development of Novel Therapeutics Targeting Aging Mechanisms (SBIR U44 Clinical Trial Not Allowed)
Notice of Change to Funding Opportunity Description of RFA-DK-20-011 "Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)"
Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
Notice of Change to Funding Opportunity Description of RFA-DK-20-012 "Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)"
Notice of Change to Key Dates for RFA-NS-18-011 "Translational Neural Devices (UG3/UH3 Clinical Trial Required)"
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
NCATS Announces Plans to Publish the ASPIRE 2020 Reduction-to-Practice Challenge Prize Competition
Notice of Special Interest: Administrative Supplements for Connecting Pre-mortem Clinical Information with Post-Mortem Brain Analysis
Notice of Change to Application Instructions for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
NIOSH Centers of Excellence for Total Worker Health (U19)
What Are the Reporting Requirements for the Inclusion Across the Lifespan Policy?
Artificial pancreas effectively controls type 1 diabetes in children age 6 and up
Glioblastoma Therapeutics Network (U19 Clinical Trial Required)
Notice to Extend RFA-MH-19-135 - BRAIN Initiative: Development of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in Human and Non-Human Primate Brain (UG3/UH3 Clinical Trial Optional)
Notice to Extend RFA-MH-20-135 BRAIN Initiative: Tools to Facilitate High-Throughput Microconnectivity Analysis (R01 Clinical Trial Not Allowed)
NCI, Cancer Research UK launch Cancer Grand Challenges partnership to support bold new ideas for cancer research
Notice of Change to Key Dates for PAR-18-940 Clinical and Translational Science Award (U54 Clinical Trial Optional)
New Annotated Form Sets: FORMS-F Series
NIH establishes Centers for Research in Emerging Infectious Diseases
Biomarkers identified in collegiate athletes that could help predict time needed to recover from concussion
Notice of NIGMS Participation in NOT-ES-20-018 Notice of Special Interest: Promoting Fundamental and Applied Research in Inflammation Resolution
Request for Information (RFI) on Encouraging AAALAC International-Accredited Institutions to Use Sections of the AAALAC Program Description in the OLAW Animal Welfare Assurance
Notice of Correction to Eligibility in NIH Funding Opportunity Announcements
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required)
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional )
Findings of research misconduct
Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
Reminder: NIH Natural Disaster Policy Hurricane Isaias, Derecho
People with intellectual and developmental disabilities disproportionately affected by COVID-19
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional)
Centers to Advance Research in Endometriosis (CARE) (P01 Clinical Trial Not Allowed)
Pre-Application Webinar for NCI Pediatric In Vivo Testing Program and NCI Pediatric In Vivo Testing Program Coordinating Center (RFA-CA-20-034, RFA-CA-20-041)
Notice of Change to RFA-AG-21-016 Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)
Reminder: AHRQ Natural Disaster Policy Hurricane Laura, Derecho
New gene associated with reduced risk for cirrhosis
Scientists use genomics to discover an ancient dog species that may teach us about human vocalization
Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins
Oral solution forms synthetic GI lining
Factors that affect depression risk
Treatments linked to drop in lung cancer deaths
Notice of Applicant Information Webinar and Frequently Asked Questions (FAQs) for Investigator-Initiated Research on Genetic Counseling Processes and Practices Request for Applications (RFAs): RFA-HG-20-048 and RFA-HG-20-049
Notice of Special Interest: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
New Sessions Available on Optimizing Animal Care and Use Program Success in a Changing Environment (ICARE Dialogues)
Notice of Special Interest: Optimizing Precision Treatment of Gynecologic, Reproductive and Obstetrical Outcomes in Adolescents and Adults with PCOS and Associated Comorbid Conditions (Clinical Trial Optional)
New “All About Grants” Podcast – Am I Doing Human Subjects’ Research?
Toward ElucidAting MechanismS Contributing to HIV Reservoirs in NIDDK-relevant Tissues (Cure TEAMS) (R01 Clinical Trial Optional)
NIH-supported study to track prevalence and impact of SARS-CoV-2 among pregnant women in low- and middle-income countries
NIH Natural Disaster Policy Reminder – Hurricane Isaias, Derecho
Statement on the Retirement of Dr. Hannah Valantine
Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Notice of Change to the Eligibility of Principal Investigators in PAR-20-042 : NCMRR Early Career Research Award (R03 Clinical Trial Optional
Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
NIH Blueprint for Neuroscience Research: Functional Neural Circuits of Interoception (R01, Clinical Trial Not Allowed)
Case Study in Review Integrity: Abuse of Power
NIH continues to boost national COVID-19 testing capacity
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)
How Do I Submit Post-Submission Materials for My Application?
Pre-Application Webinar for RFA-ES-20-001 "Collaborative Centers in Children's Environmental Health Research and Translation (P2C Clinical Trial Optional)"
Pre-Application Webinars for RFA-CA-20-047, Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
Notice of Intent to Publish Funding Opportunity Announcement to Improve the Nonsurgical Management of Urinary Incontinence in Women
Notice of Correction to Eligibility Information for PAR-20-263 "Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)"
Notice of Special Interest: Advancing the Science of Geriatric Palliative Care
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trial Not Allowed)
Genomic Data Analysis Network: Genomic Data Center (U24 Clinical Trial Not Allowed)
Templeton Prize features 2020 recipient Dr. Collins
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Pre-Application Webinar for RFA-CA-20-040, Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)
NIEHS SBIR Phase IIB Validation of Sensors for Improved Environmental Exposure Assessment (R44 Clinical Trial Not Allowed)
Notice of Change to Application Due Date for RFA-DA-21-009, "Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)"
Notice of Special Interest (NOSI): Research in the Emergency Setting
Applications To NIH Loan Repayment Programs Accepted Sept. 1 Through Nov. 20
Free Registration for the Fall 2020 NIH Virtual Seminar on Program Funding and Grants Administration!
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
Notice of Extension of the Expiration Date for PAR-18-367 "NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)"
Notice of Special Interest (NOSI): Palliative Care in Heart, Lung, Blood, and Sleep Diseases
Miglustat improves swallowing in children and adolescents with Niemann-Pick type C1 disease
Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed)
Notice of Special Interest (NOSI): Training Modules for Creating Safe, Inclusive, and Supportive Research Environments
Notice of Special Interest: Alzheimers-focused administrative supplements for NIH grants that are not focused on Alzheimers disease
Testimony on Vaccines: Saving Lives, Ensuring Confidence, and Protecting Public Health
Study shows decline in awareness, treatment and control of high blood pressure
Probiotic skin therapy improves eczema in children, NIH study suggests
Notice of Expiration of PAR-18-923 - Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
Notice of Expiration of PAR-19-307 " Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)"
NIMHD Loan Repayment Program Technical Assistance Webinar
Reissue of Parent Research Supplements to Promote Diversity in Health-Related Research FOA in October 2020
Notice of Extension of the Expiration Date for PAR-18-365 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)"
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional)
Notice of Extension of the Expiration Date for PAR-18-366 "NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials)"
Updated Information on the Research Projects Component for PAR-20-297 NIOSH Centers of Excellence for Total Worker Health (U19)
Reminder: NIH Natural Disaster Policy Hurricane Laura
NOTICE of eligibility change for PAR-18-901: Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43)
Notice of Extension of the Expiration Date for PAR-18-337 "NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08, No Independent Clinical Trials)"
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Scientific Data Research Center (U24 Clinical Trial Required)
Limited Competition for the Continuation of the Urinary Stone Disease Research Network (USDRN) Clinical Centers (U01 Clinical Trial Required)
Notice of Extension of the Expiration Date for PAR-18-364 "NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)"
Notice of Special Interest (NOSI): Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design
NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19
Dr. Collins joins NBC News’ Dr. John Torres for Doc to Doc Facebook Live series
Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood clotting treatments for COVID-19
Dr. Collins answers questions from Anderson Cooper, Dr. Sanjay Gupta and viewers during a CNN Coronavirus Town Hall
Notice of Special Interest: Administrative Supplement for the NINDS Research Education Program for Residents and Fellows in Neurology, Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supp)
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Notice of Limited Availability of Research Non-human Primates
Notice of Special Interest: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
Policy for Charging Personal Protective Equipment to NIH Grants and Cooperative Agreements as Direct Costs
Dr. Collins speaks to MSNBC about safety protocols for COVID-19 vaccine research
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed)
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed)
HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
HeartShare: Next-Generation Phenomics to Define Heart Failure Subtypes (U01 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-NS-18-020 "BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
Substance use disorders linked to COVID-19 susceptibility
NIH augments large scale study of Alzheimer’s disease biomarkers
How high fructose intake may trigger fatty liver disease
Brain scans may help predict response to OCD therapies
Artificial pancreas helps children with type 1 diabetes
Notice of Change: Expansion of Research Scope of RFA-OD-19-029 The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)"
Notice of Expiration of PA-17-247 - Implementation and Evaluation of New Health Information Technology (IT) Strategies for Collecting and Using Patient-Reported Outcome (PRO) Measures (U18)
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Notice of Application Form Issue with PAR-18-798 Occupational Safety and Health Research (R21)
Notice of Extension of the Expiration Date for PAR-18-336 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trial Required)
Notice of Change to Key Dates for RFA-NS-18-019 "BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
Notice of Application Form Issue with PAR-18-812 Occupational Safety and Health Research (R01)
Notice of Application Form Issue with PAR-18-797 NIOSH Small Research Grant Program (R03)
Notice of Application Form Issue with PAR-18-799 NIOSH Mentored Research Scientist Development Award (K01)
Social and Behavioral Intervention Research to Address Modifiable Risk Factors for Cancer in Rural Populations (R01 Clinical Trial Required)
NIH public-private partnership to advance early interventions for schizophrenia
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (UG3/UH3 Clinical Trial Required)
New “All About Grants” Podcast – Research Misconduct
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI)
Vaping, marijuana use in 2019 rose in college-age adults
NIH awards contracts to develop innovative digital health technologies for COVID-19
Reminder: NIH Policy on Use of Hypertext in NIH Grant Applications
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Dr. Collins joins ABC News’ Vaccine Watch to provide an update on COVID-19 vaccine developments
NIH Natural Disaster Policy Reminder – Hurricane Laura and Wildfires
NIH funds community engagement research efforts in areas hardest hit by COVID-19
BRAIN Initiative: Pilot resources for brain cell type-specific access and manipulation across vertebrate species (U01 Clinical Trial Not Allowed)
NIAID Research Education Program (R25 Clinical Trial Not Allowed)
Statement on the Departure of Debra Chew
Cancer Intervention and Surveillance Modeling Network (CISNET) Incubator Program for New Cancer Sites (U01 Clinical Trial Not Allowed)
Drug Development Collaboratory (UG3/UH3 Clinical Trial Required)
Request for Information: Ambitious Collaborative Goals for Bioelectronic Medicine
Pre-Application Webinar for RFA-TR-20-030, Multi-disciplinary Machine-assisted, Genomic Analysis and Clinical Approaches to Shortening the Rare Diseases Diagnostic Odyssey (UG3/UH3 Clinical Trial Not Allowed)
Clarification of the Role of the Intramural Investigator in PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
Request for Information: Response to Proposed NIH Rehabilitation Research Plan Objectives
Update for PAR-20-280 "Cooperative Research Agreements Related to the World Trade Center Health Program (U01)"
Update for RFA-OH-21-004 "Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)"
Update for RFA-OH-21-003 "Extension of the World Trade Center Health Registry (U50)"
Notice of Change to Key Dates for RFA-OH-20-001 Miner Safety and Health Training Program - Western United States (U60)
Notice of Change to RFA-AG-21-016 "Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)"
Notice of Clarification to the NIBIB R21 Trailblazer Program (PAR-20-084)
NIH study details self-reported experiences with post-exertional malaise in ME/CFS
Biomarkers predict concussion recovery time
Bacteria therapy improves eczema in children
High blood pressure awareness and treatment declining
Limited Competition for Continuation of the Integrated Islet Distribution Program (U24 Clinical Trial Not Allowed)
Pediatric and Reproductive Environmental Health Scholars (PREHS): Strengthening the Pipeline (K12 Clinical Trial Not Allowed)
Notice of NIAID's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
Notice of FY2021 Cohort Dates for PA-19-029, Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
Notice of NIAID's Participation in PAR-19-342: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 Clinical Trial Not Allowed)
Review of the Accuracy of Grants Information for Fiscal Year 2020
Notice of Correction for RFA-AA-20-009 "Alcohol-HIV/AIDS Program Project Comorbidities, Coinfections, and Complications Research: Intervention and Cross-Cutting Foundational Research (P01 Clinical Trial Optional)"
Otolaryngology Residency Mentored Research Pathway (R25 Clinical Trial Not Allowed)
Negative pressure wound therapy does not cut infection risk in obese women after cesarean delivery
NIH expands clinical trials to test convalescent plasma against COVID-19
Notice of Special Interest: Administrative Supplements for NIA-VA Mentored Physician-Scientist Award in Alzheimers Disease and its Related Dementias (AD/ADRD)
Changes to the HHS Notice of Award (NoA) Beginning October 1, 2020
Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)
Notice of Correction to PAR-20-295 Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection In Vivo (R01 Clinical Trials optional)
Notice of Change to RFA-OD-20-016, "Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)"
Fourth large-scale COVID-19 vaccine trial begins in the United States
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21 Clinical Trial Not Allowed)
Notice of Change to NIEHS target FOAs for NOT-HL-20-788 "Notice of Special Interest (NOSI): Stimulating Intervention Research to Reduce Cardiopulmonary Impacts of Particulate Matter in Air Pollution among High-Risk Populations"
Notice of Change to Key Dates for RFA-NS-19-003 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-NS-19-001 "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)"
Notice of Change in Application Types Allowed for PAR-19-070 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
State Occupational Safety and Health Surveillance Program (U60)
Notice of Correction to Application Submission Information for NOT-MD-20-025 "Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities"
Limited Competition for the Continuation of Clinical Centers to Investigate the Pathogenesis, Etiology, and Treatment of Gastroparesis through the NIDDK Gastroparesis Consortium (U01 Clinical Trial Optional)
Pre-Application Webinar for NCATS RFA-TR-20-031 and RFA-TR-20-032, Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases
NHLBI Announces Availability of Frequently Asked Questions (FAQs) for RFA-HL-21-001 "Hybrid Effectiveness-Implementation Trials for Heart, Lung, Blood, and Sleep Diseases in the Inpatient Setting (U01 - Clinical Trials Required)"
Limited Competition for the Continuation of the Scientific Data Research Center (SDRC) for the NIDDK Gastroparesis Consortium (U24 Clinical Trial Optional)
Understanding Evolutionary Dynamics of Influenza to Inform and Improve Vaccine Strain Selection (R01 Clinical Trial Not Allowed)
Notice of NIMHD Participation in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)"
Using Syndemics to Understand HLBS Disease Emergence and Progression in People with HIV (PWH)(R01 Clinical Trial Not Allowed)
Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01 Clinical Trial Not Allowed)
Notice of Change to Key Dates for RFA-NS-19-002 "BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Clinical Trial Required)
Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19
Notice of NHLBI Participation in RFA-OD-19-029: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Request for Information (RFI): Pediatric preclinical models (cell lines and patient-derived xenografts) for which genomic characterization will enhance research value
BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)
Reminder: NIH Natural Disaster Policy Wildfires
Notice of Special Interest (NOSI): Administrative Supplements to NCATS CTSA Program KL2 Institutional Career Development Awards as part of the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project
Notice of Change to Due Date for PAR-19-342: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5)
NIMHD Withdraws Participation in NOT-MD-20-022 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations"
Guidance on Charging Personal Protective Equipment for Grants that Support Clinical Trials and Clinical Research
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required)
Notice of Correction to Page Limitation Instructions for RFA-DK-20-017: Chronic Kidney Diseases of UnceRtain Etiology (CKDu) in Agricultural Communities (CURE) Research Consortium - Field Epidemiology Sites (U01 Clinical Trial Not Allowed)
NIH-funded study sheds light on abnormal neural function in rare genetic disorder
About 14% of cerebral palsy cases may be tied to brain wiring genes
Poor immune response impairs diabetic wound healing
Computer-designed proteins may protect against coronavirus
How anesthetics and benzodiazepine affect the brain differently
Changes to Budget/Project Period for Commercial Fishing Occupational Safety Training Project Grants (T03)
Notice for All of Us Research Program - National, State, and Local Engagement Partner Funding Opportunity (OT2) and Informational Webinar
Understanding the Role of the M. Tuberculosis Granuloma in Tuberculosis (TB) Disease and Treatment Outcomes (R01 Clinical Trial Not Allowed)
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
NIMHD Withdraws Participation in NOT-MD-20-019 "Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities"
Notice of Special Interest (NOSI): Clarification of the Objectives and Program Elements in NHGRI Applications Submitted in Response to the "Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)"
Notice of Special Interest (NOSI) Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
Changes to Budget/Project Period for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults
Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function
Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2021 Councils
Required Submission of Financial Conflict of Interest Policy into the eRA Commons Institution Profile (IPF) Module
Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic
Cohort Studies To Improve Our Understanding of Influenza Immunity, Vaccine Response and Effectiveness in Older Adults (65 years and older) (U01 Clinical Trial Not Allowed)
Notice of Correction to PAR-20-225, " Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)"
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed)
NIH to assess and expand COVID-19 testing for underserved communities
NIH funds first nationwide network to study rare forms of diabetes
Notice of Special Interest: Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens
Reminder: Annual Reports to the Office of Laboratory Animal Welfare due December 1, 2020
Requirement for Trainee Diversity Report to be Submitted Electronically for Institutional Research Training, Career Development, and Research Education Awards Beginning in Early FY 2021
More Thoughts on Cyber Safety and NIH-Funded Research
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 Clinical Trial Not Allowed)
Reminder: NIH Policy on Use of Hypertext in NIH Grant Applications
Register for the 2020 NIH Virtual Seminar on Program Funding and Grants Administration - Oct. 27-30
Notice of Change to Receipt Date for RFA-HG-20-014, RFA-HG-20-015, and RFA-HG-20-016: NHGRI Synthetic Nucleic Acid Technology Development FOAs
Request for Information on Processes for NRGR Sample Submission, Access, and Management
Notice of Change: Correction of Calendar Months Expected To Be Devoted on RFA-HG-20-044 and RFA-HG-20-047 which are part of the "Impact of Genomic Variation on Function Consortium"
Consolidated Notice on NIMH Clinical Trials Policies
Notice of Intent to Publish a Funding Opportunity Announcement for Aging Effects on Osteoimmunology (Clinical Trials Not Allowed)
Notice of Clarification to the High-Risk, High-Reward Research Program: Pioneer: RFA-RM-20-011, New Innovator: RFA-RM-20-012, Transformative Research (RFA-RM-20-013, RFA-RM-20-020 and NOT-RM-20-019), and Early Independence (RFA-RM-20-014 and RFA-RM-20
Program Officials Are Here to Help
Encouraging Participation in Upcoming NIH Surveys to Identify Impacts of COVID-19 on Extramural Research
Notice of Extension of the Expiration Date of PAR-19-363 "Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)"
Friendlier Approach for Cross-Referencing NOSIs in FOAs Used for Submission
NIH intramural researcher Dr. Harvey Alter wins 2020 Nobel Prize in Physiology or Medicine
T-21 Days Left Until the NIH Virtual Seminar on Program Funding and Grants Administration
Telebriefing: NIH intramural researcher Harvey J. Alter wins 2020 Nobel Prize in Physiology or Medicine
NIH scientists reveal how the brain may fuel intense neural communication
Required Submission of Financial Conflict of Interest Policy into the eRA Commons Institution Profile (IPF) Module
NIH-funded study suggests link between pediatric hospitalization and rising unemployment
Machine learning detects early signs of osteoarthritis
SARS-CoV-2 may use key carbohydrate to infect cells
Pain rising among younger Americans with less education
Notice of Early Termination of PAR-18-909, Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 Clinical Trial Not Allowed)
Notice of Early Termination of PAR-18-910, Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)
Pre-Application Webinar for RFA-CA-20-053, Genomic Data Analysis Network: Genomic Data Analysis Center (U24 Clinical Trial Not Allowed)
NIAMS Policy for Acceptance of Clinical Trial Applications and Participation in Parent R01 and R21(Clinical Trial Required) Announcements
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
NIH to support 85 new grants featuring high-risk, high-reward research
NIH RADx initiative advances six new COVID-19 testing technologies
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed)
A Multidisciplinary Approach to Study Vaccine-elicited Immunity and Efficacy against Malaria (U01 Clinical Trial Not Allowed)
Notice of Correction to RFA-CA-20-052 Limited Competition: Childhood Cancer Survivor Study (U24 Clinical Trial Required)
Request for Information: Data Science Challenges and Opportunities in the Field of Precision Nutrition
Mouse study suggests parental response to infant distress is innate but adapts to change
Coccidioidomycosis Collaborative Research Centers (U19 Clinical Trial Not Allowed)
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional)
Notice of Extension to PA-18-350, "NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)"
NIH to launch the Serological Sciences Network for COVID-19, announce grant and contract awardees
NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 Begins
Notice of Technical Assistance Webinar and Frequently Asked Questions (FAQs) for NHLBI HeartShare RFA-HL-21-015 "Clinical Centers (U01)" and RFA-HL-21-016 "Data Translation Center (U54)"
Notice to Extend the Expiration Date for PAR-18-433 "NIBIB Exploratory/Developmental Research Grant Program (R21 Clinical Trial Optional)"
Notice of Correction to RFA-CA-20-047 Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)"
Notice to Extend the Response Due Date for NOT-DA-20-073 "Request for Information (RFI):Advancing Biomarker Research and Implementation to Personalize Health Services Delivery for Tobacco Use Disorder"
NEI Notice of Participation in PAR-19-093: "Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)"
Utilizing In Vitro Functional Genomics Advances for Gene-Environment (G x E) Discovery and Validation (R01 Clinical Trial Not Allowed)
Notice of NCATS Interest in Receiving Letters Requesting Permission to Submit Applications to Support Annual Microphysiological Systems Scientific Conferences (U13)
Welcome the New RePORT and RePORTER Tools!
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
NIH-funded study links adolescent brain differences to increased waist circumference
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
NHGRI researchers work with patients, families and the scientific community to improve the informed consent process
NIH study aims to identify promising COVID-19 treatments for larger clinical trials
Notice of Change to PAR-19-315 "Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)"
Notice of NHLBI Participation in PA-20-227, "Administrative Supplements for Research on Dietary Supplements (Admin Supp Clinical Trial Not Allowed)"
Change of the Award Project Period for PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
NIMHD Withdraws Participation in NOT-MH-20-047 "Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus"
NIMHD Withdraws Participation in NOT-MH-20-053 "Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19"
Notice of Change to Budget Information and Key Dates for PAR-20-026, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed)"
Request for Information: Guidance on Current Research on the Prevention of Black Youth Suicide
Notice of Extension to RFA-MH-18-700, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-701, "Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-702, "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33- Clinical Trial Required)"
Notice of Extension to RFA-MH-18-705, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-706, "Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required)"
Notice of Extension to RFA-MH-18-707, "Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required"
Notice of Extension to RFA-MH-18-703, "Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)"
Notice of Special Interest: Integrative Studies of Neural Mechanisms Underlying Fundamental Affective Processes in Aging
Notice of Extension to RFA-MH-18-704, "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33- Clinical Trial Required)"
Notice of Change to Budget Information and Key Dates for PAR-20-027, "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed)"
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not Allowed)
New Cohorts for Environmental Exposures and Cancer Risk (CEECR) Coordinating Center (U24 Clinical Trial Not Allowed)
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource Core (U24) (Clinical Trial Optional)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24) (Clinical Trial Optional)
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Optional)
Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Optimizing Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
From Genomic Association to Causation: A Convergent Neuroscience Approach to Linking Levels of Analysis for Understanding Neuropsychiatric Disorders (U19 Clinical Trial Optional)
Notice to Extend the Response Date for NOT-MH-20-073, "Request for Information (RFI): Fostering Innovative Research to Improve Mental Health Outcomes Among Minority and Health Disparities Populations"
Developing a Culture of Safety in Biomedical Research Training
Notice of Special Interest (NOSI): Administrative Supplements for Minor Alterations and Renovations to Advance Ongoing HIV/AIDS Research Projects Supported by the NIMHD RCMI Program or the NIGMS IDeA and NARCH Programs
Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)
Notice of Policy Revision: Managing Conflicts of Interest for Requests for Applications (RFAs)
NIH begins large clinical trial to test immune modulators for treatment of COVID-19
Dr. Collins joins Skimm This podcast to discuss COVID-19 vaccine timelines and staying vigilant about COVID-19 safety guidelines
Notice of Special Interest: Administrative Supplements to Support Dentist Scientists Post Specialty or Residency to Develop Expertise in Dental, Oral and Craniofacial Research
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed)
Notice of Change to Key Dates for PAS-18-483 "Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed)"
Notice Announcing Availability of Data Harmonization Tools for Social Determinants of Health (SDOH) via the PhenX Toolkit
Notice of the NIH Office of Disease Preventions Participation in PAR-20-238: Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Notice of the NIH Office of Disease Preventions Participation in PAR-20-214: Research to Improve Native American Health (R21 Clinical Trials Optional)
NIH study tests a comprehensive model intervention to reduce opioid overdose deaths in hard-hit communities
Additional Research Area of Interest for RFA-OH-21-004 "Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21)"
Change in Award Budget Ceiling for Commercial Fishing Occupational Safety Research Cooperative Agreement (U01)
Change in Award Budget Ceiling for Commercial Fishing Occupational Safety Training Project Grants (T03)
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Study discovers gene that helps us know when it’s time to urinate
Education programs may improve young children’s asthma control
Brain differences in youth linked to increased waist size
Final report confirms remdesivir benefits for COVID-19
Notice to Extend the Response Date for NOT-LM-20-015, "Request for Information (RFI): Strategic Opportunities and Challenges for the National Library of Medicine, National Institutes of Health".
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Quick Links

IRB & Human Subjects
NIH Public Access Policy
PSC Library Catalog
Sociology Department
Economics Department
DONATE TO THE PSC

Request Services

Reserve the PSC Conference Room and/or Collaboration Space
Submit a Working Paper/Brief
Submit News & Events

About Us

The Population Aging Research Center (PARC) at the University of Pennsylvania has over 25 years of experience of creating the right setting for interdisciplinary research on the demography and economics of aging, including a focus on diverse and often underrepresented populations domestically and globally. The Population Aging Research Center (PARC) was established in 1994 with a grant from the National Institute on Aging. PARC sponsors an annual pilot proposal competition, a weekly seminar series in conjunction with the Population Studies Center, the Penn Population Studies Colloquium and an online working paper series, the Population Center Working Papers (PSC/PARC). The overall research themes of PARC reflect the interests and expertise of our research associates. These include: Health Care and Long-Term Care in Older Adults, Cognition and Alzheimer's Disease and Related Dementia (ADRD), Health Disparities in Aging, Early Life-Conditions and Older Adult Health, Behavior and Well-Being, and Global Aging and Health.

Contact

Tel: 215-898-6441
Fax: 215-898-2124

239 McNeil Building
3718 Locust Walk
Philadelphia, PA 19104-6298
[Map & Directions]

twitter.com/pennparc

facebook.com/pennpsc

Penn A-Z - Penn Calendar

© 2020 The Trustees of the University of Pennsylvania

Population Aging Research Center